Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study

OBJECTIVE: Ischemia-modified albumin (IMA) is a sensitive biomarker of myocardial ischemia. However, data on IMA levels in acute heart failure (HF) are still lacking. In this study, we aimed to evaluate serum IMA levels in acute decompensated HF and the effects of dobutamine and levosimendan treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Çavuşoğlu, Yüksel, Korkmaz, Şule, Demirtaş, Selda, Gencer, Erkan, Şaşmaz, Hatice, Mutlu, Fezan, Güneş, Hakan, Mert, Uğur Kadir, Özdemir, Sedat, Kalaycı, Süleyman, Yılmaz, Mehmet Birhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2016
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336859/
https://www.ncbi.nlm.nih.gov/pubmed/26301344
http://dx.doi.org/10.5152/akd.2015.6156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336859/
https://www.ncbi.nlm.nih.gov/pubmed/26301344
http://dx.doi.org/10.5152/akd.2015.6156

Ejemplares similares